V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20031155 | 20013297 | 1.7 | 58 | Neo-adjuvant (N) | 2015-01-14 | 2015-01-17 | FEC + DOCETAXEL | 2 | N | 20109638 | FEC + DOCETAXEL |
| 20031156 | 20013297 | 1.73 | 86.8 | Not known (9) | 2018-01-11 | 2018-02-02 | FEC 100 + DOCETAXEL | N | N | 20109638 | FEC + DOCETAXEL |
| 20031157 | 20013298 | null | null | Adjuvant (A) | 2017-01-09 | 2017-02-05 | FEC + DOCETAXEL | 2 | N | 20109642 | FEC + DOCETAXEL |
| 20031158 | 20013299 | 1.58 | 64.2 | Neo-adjuvant (N) | 2014-09-16 | 2014-10-08 | FEC 100 + DOCETAXEL | N | N | 20109643 | FEC + DOCETAXEL |
| 20031159 | 20013299 | 1.57 | 60.1 | Not known (9) | 2013-07-10 | 2013-07-24 | FEC 100 + DOCETAXEL | N | N | 20109643 | FEC + DOCETAXEL |
| 20031160 | 20013299 | 1.62 | null | Adjuvant (A) | 2016-06-22 | 2016-07-18 | FEC + DOCETAXEL | 02 | null | 20109643 | FEC + DOCETAXEL |
| 20031161 | 20013299 | 1.54 | 64.4 | Adjuvant (A) | 2018-01-25 | 2018-01-25 | FEC 100 + DOCETAXEL | 2 | N | 20109643 | FEC + DOCETAXEL |
| 20031162 | 20013300 | 1.58 | 67.8 | Neo-adjuvant (N) | null | 2017-12-25 | FEC 100 + DOCETAXEL | N | N | 20109660 | FEC + DOCETAXEL |
| 20031163 | 20013300 | null | null | Adjuvant (A) | 2015-12-25 | 2016-01-24 | FEC + DOCETAXEL | N | null | 20109660 | FEC + DOCETAXEL |
| 20031164 | 20109374 | 1.66 | 64 | Adjuvant (A) | null | 2016-08-27 | FEC 100 + DOCETAXEL | N | N | 20109666 | FEC + DOCETAXEL |
| 20031165 | 20109374 | 1.74 | 100 | Not known (9) | 2016-02-16 | 2016-02-27 | FEC + DOCETAXEL | 02 | N | 20109666 | FEC + DOCETAXEL |
| 20031166 | 20013301 | 1.62 | 99.6 | Curative (C) | 2015-10-17 | 2015-12-28 | FEC + DOCETAXEL | 2 | N | 20109668 | FEC + DOCETAXEL |
| 20031167 | 20013302 | 1.63 | 62 | Curative (C) | null | 2017-04-29 | FEC 100 + DOCETAXEL | N | N | 20109670 | FEC + DOCETAXEL |
| 20031168 | 20013302 | null | null | Adjuvant (A) | 2014-05-23 | 2014-06-06 | FEC + DOCETAXEL | N | N | 20109670 | FEC + DOCETAXEL |
| 20031169 | 20013303 | 1.59 | 61.4 | Adjuvant (A) | null | 2017-05-25 | FEC 100 + DOCETAXEL | N | N | 20109673 | FEC + DOCETAXEL |
| 20031170 | 20013303 | 1.64 | 76.5 | Not known (9) | null | 2018-01-07 | FEC + DOCETAXEL | N | N | 20109673 | FEC + DOCETAXEL |
| 20031171 | 20013303 | null | 64.699 | Neo-adjuvant (N) | 2015-12-31 | 2016-01-04 | FEC 100 + DOCETAXEL | N | N | 20109673 | FEC + DOCETAXEL |
| 20031172 | 20013303 | 1.67 | 104 | Adjuvant (A) | 2017-06-03 | 2017-06-24 | FEC + DOCETAXEL | 02 | N | 20109673 | FEC + DOCETAXEL |
| 20031173 | 20013304 | null | 75.8 | Neo-adjuvant (N) | 2015-04-29 | 2015-05-24 | FEC + DOCETAXEL | N | N | 20109688 | FEC + DOCETAXEL |
| 20031174 | 20013304 | 1.7 | null | null | 2016-01-04 | 2016-02-03 | FEC + DOCETAXEL | N | null | 20109688 | FEC + DOCETAXEL |
| 20031175 | 20013305 | null | null | null | 2017-09-25 | 2017-09-30 | FEC + DOCETAXEL | 2 | n | 20109695 | FEC + DOCETAXEL |
| 20031176 | 20013305 | 1.58 | 93 | Curative (C) | 2013-03-27 | 2013-04-01 | FEC + DOCETAXEL | 02 | N | 20109695 | FEC + DOCETAXEL |
| 20031177 | 20013306 | null | null | Neo-adjuvant (N) | 2017-03-26 | 2017-04-13 | FEC 100 + DOCETAXEL | 2 | null | 20109699 | FEC + DOCETAXEL |
| 20031178 | 20013307 | 1.58 | null | Adjuvant (A) | 2017-05-22 | 2017-05-29 | FEC + DOCETAXEL | N | N | 20109704 | FEC + DOCETAXEL |
| 20031179 | 20013307 | 1.57 | 65.7 | Not known (9) | 2015-01-09 | 2015-01-21 | FEC + DOCETAXEL | N | N | 20109704 | FEC + DOCETAXEL |
| 20031180 | 20013307 | 1.57 | 62.3 | Neo-adjuvant (N) | 2013-10-31 | 2013-11-06 | FEC + DOCETAXEL | 02 | N | 20109704 | FEC + DOCETAXEL |
| 20031181 | 20013307 | 1.6 | 82.6 | Disease modification (D) | 2013-04-29 | 2013-05-06 | FEC + DOCETAXEL | 2 | N | 20109704 | FEC + DOCETAXEL |
| 20031182 | 20013308 | 1.46 | 71 | Adjuvant (A) | 2014-09-13 | 2014-09-13 | FEC + DOCETAXEL | 02 | N | 20109722 | FEC + DOCETAXEL |
| 20031183 | 20013308 | 1.71 | 50.4 | Neo-adjuvant (N) | null | 2017-10-05 | FEC + DOCETAXEL | N | N | 20109722 | FEC + DOCETAXEL |
| 20031184 | 20013308 | null | 52 | Adjuvant (A) | 2015-12-12 | 2015-12-13 | FEC + DOCETAXEL | N | N | 20109722 | FEC + DOCETAXEL |
| 20031185 | 20013308 | 1.74 | 87.3 | Curative (C) | null | 2015-03-26 | FEC + DOCETAXEL | N | N | 20109722 | FEC + DOCETAXEL |
| 20031186 | 20013309 | 1.67 | 64 | Palliative (P) | null | 2015-06-10 | FEC + DOCETAXEL | N | N | 20109734 | FEC + DOCETAXEL |
| 20031187 | 20013309 | 1.67 | 71.8 | Adjuvant (A) | 2017-05-05 | 2017-05-31 | FEC 100 + DOCETAXEL | 02 | N | 20109734 | FEC + DOCETAXEL |
| 20031188 | 20013310 | 1.52 | 60 | Neo-adjuvant (N) | 2017-04-14 | 2017-04-14 | FEC + DOCETAXEL | 02 | null | 20109752 | FEC + DOCETAXEL |
| 20031189 | 20013310 | 1.54 | 74 | Neo-adjuvant (N) | 2016-10-30 | 2016-11-16 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20109752 | FEC + DOCETAXEL |
| 20031190 | 20109378 | 1.69 | 57 | Adjuvant (A) | 2017-09-21 | 2017-09-21 | FEC 100 + DOCETAXEL | 02 | N | 20109754 | FEC + DOCETAXEL |
| 20031191 | 20013311 | 1.66 | null | Adjuvant (A) | 2016-11-17 | 2016-12-09 | FEC + DOCETAXEL | N | N | 20109755 | FEC + DOCETAXEL |
| 20031192 | 20013312 | 1.57 | 110.4 | Adjuvant (A) | 2016-08-05 | 2016-08-17 | FEC + DOCETAXEL | 2 | null | 20109756 | FEC + DOCETAXEL |
| 20031193 | 20013312 | 1.61 | 68.6 | Curative (C) | 2016-09-13 | 2016-09-18 | FEC + DOCETAXEL | N | N | 20109756 | FEC + DOCETAXEL |
| 20031194 | 20013312 | null | 89.6 | Neo-adjuvant (N) | 2013-07-20 | 2013-08-09 | FEC + DOCETAXEL | 2 | N | 20109756 | FEC + DOCETAXEL |
| 20031195 | 20013313 | 1.65 | 74.8 | Adjuvant (A) | 2014-01-08 | 2014-01-10 | FEC + DOCETAXEL | 02 | N | 20109766 | FEC + DOCETAXEL |
| 20031196 | 20013313 | null | null | Adjuvant (A) | 2014-06-15 | 2014-06-26 | FEC 100 + DOCETAXEL | N | Y | 20109766 | FEC + DOCETAXEL |
| 20031197 | 20013314 | 1.73 | 90.1 | Adjuvant (A) | 2014-01-28 | 2014-02-01 | FEC 100 + DOCETAXEL | 02 | N | 20109770 | FEC + DOCETAXEL |
| 20031198 | 20013315 | 1.54 | 94 | Adjuvant (A) | 2017-08-06 | 2017-08-06 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20109776 | FEC + DOCETAXEL |
| 20031199 | 20013315 | null | 54 | null | 2014-11-25 | 2014-12-02 | FEC 100 + DOCETAXEL | N | N | 20109776 | FEC + DOCETAXEL |
| 20031200 | 20013316 | 1.73 | 71.1 | null | 2013-09-05 | 2013-10-03 | FEC + DOCETAXEL | 2 | N | 20109799 | FEC + DOCETAXEL |
| 20031201 | 20013316 | 1.61 | 87.4 | Adjuvant (A) | 2013-12-22 | 2014-01-12 | FEC 100 + DOCETAXEL | N | N | 20109799 | FEC + DOCETAXEL |
| 20031202 | 20013317 | 1.62 | 86.7 | Adjuvant (A) | 2018-01-18 | 2018-01-27 | FEC 100 + DOCETAXEL | N | N | 20109812 | FEC + DOCETAXEL |
| 20031203 | 20013318 | null | 71.9 | null | 2015-07-18 | 2015-07-18 | FEC + DOCETAXEL | N | N | 20109813 | FEC + DOCETAXEL |
| 20031204 | 20013318 | 1.61 | 67.6 | Neo-adjuvant (N) | 2016-08-31 | 2016-09-17 | FEC + DOCETAXEL | N | N | 20109813 | FEC + DOCETAXEL |